News
I
Jun 09, 2025
SIM01 Research Named in Global Top 30 (2022-2025)
Announced at China Gut Conference 2025, our SIM01 study, led by Prof. Siew Ng, Prof. Francis Chan, and team, and published in The Lancet Infectious Diseases, has been selected as one of the Top 30 Global Research Papers (2022–2025) in the Global Evidence-based Database (GEBD) for Health Outcomes of Pro/Prebiotics (HOPE).
A proud milestone for G-NiiB GenieBiome and a powerful validation of our mission to deliver real-world health impact through microbiome innovation.
Details: https://lnkd.in/gpmTu-xk
SIM01 Research: https://lnkd.in/ggVQqw4H
.jpg "SIM01 Research Named in Global Top 30 (2022-2025)")
